首页> 美国卫生研究院文献>other >Most Basal-like Breast Carcinomas Demonstrate the Same Rb−/p16+ Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically
【2h】

Most Basal-like Breast Carcinomas Demonstrate the Same Rb−/p16+ Immunophenotype as the HPV-related Poorly Differentiated Squamous Cell Carcinomas Which They Resemble Morphologically

机译:大多数基底样乳腺癌表现出与形态相似的HPV相关的鳞状上皮细胞癌相关的Rb- / p16 +免疫表型。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Basal-like carcinomas (BLCs) of the breast share discriminatory morphologic features with poorly differentiated high-risk human papilloma virus (HPV)-related squamous cell carcinomas of the oropharynx, penis, and vulva. Because HPV E7 protein inactivates the retinoblastoma (Rb) protein, diffuse p16 expression is a surrogate marker for these high-risk HPV-related carcinomas. HPV E6 protein also inactivates p53, further compromising the G1-S cell cycle checkpoint. The Rb/p16/p53 immunohistochemical profile of BLC of the breast has not been well characterized. Tissue microarrays containing 71 invasive ductal carcinomas (IDCs) of the breast were immunolabeled for p16, Rb, p53, and Ki-67. The cases included 4 distinct groups of IDCs having surrogate immunohistochemical profiles corresponding to categories defined by gene expression profiling (17 luminal A, 7 luminal B, 14 HER-2+, and 21 BLC), along with 12 unclassifiable triple negative carcinomas (UTNCs). Twenty-five of the 71 IDC were Rb negative/p16 diffuse positive (Rb −/p16+). These included 15 of 21 BLC and 9 of 12 UTNC, but only 1 of 14 HER-2 positive cases and none of the 17 luminal A or 7 luminal B cases (P < 0.01, BLC or UTNC vs. others). Six of the Rb − /p16+ IDC also had a significant ductal carcinoma in situ component. The ductal carcinoma in situ in 4 of these 6 cases showed the same Rb − /p16+ phenotype as the associated IDC. BLC and UTNC had the highest Ki-67 indices of the 5 groups, even when matched for grade. The Rb − /p16+ phenotype and the Rb − /p16+/p53 overexpressing phenotype correlated with increased proliferation within the BLC group. In conclusion, BLC and UTNC, but not HER-2, luminal A, or luminal B carcinomas, frequently demonstrate an Rb − /p16+ phenotype, similar to the HPV-related squamous cell carcinomas that BLC resemble morphologically. This subset may represent a more homogenous group than BLC as defined currently.
机译:乳腺的基底样癌(BLC)具有区分性的形态学特征,口咽,阴茎和外阴的高分化人类高危型人乳头瘤病毒(HPV)相关鳞状细胞癌。由于HPV E7蛋白使视网膜母细胞瘤(Rb)蛋白失活,因此弥漫性p16表达是这些高危HPV相关癌的替代标志物。 HPV E6蛋白还会使p53失活,从而进一步损害G1-S细胞周期检查点。乳腺BLC的Rb / p16 / p53免疫组织化学谱图尚未得到很好的表征。对包含71个乳腺浸润性导管癌(IDC)的组织微阵列进行了p16,Rb,p53和Ki-67免疫标记。这些病例包括4个不同的IDC组,它们具有与基因表达谱所定义的类别相对应的替代免疫组织化学特征(17个腔A,7个腔B,14个HER-2 +和21个BLC),以及12个无法分类的三阴性癌(UTNC)。 。 71个IDC中有25个是Rb阴性/ p16扩散阳性(Rb-/ p16 +)。其中包括21例BLC中的15例和12例UTNC中的9例,但是14例HER-2阳性病例中只有1例,而17例A管腔或7例B管腔的病例均无(P <0.01,BLC或UTNC对其他)。 Rb-/ p16 + IDC中的六个也具有显着的导管癌原位成分。这6例病例中有4例的原位导管癌表现出与相关IDC相同的Rb-/ p16 +表型。即使等级匹配,BLC和UTNC仍是5组中Ki-67指数最高的指标。 Rb-/ p16 +表型和Rb-/ p16 + / p53过表达表型与BLC组内增殖增加有关。总之,BLC和UTNC,而不是HER-2,管腔A或管腔B癌,经常表现出Rb-/ p16 +表型,类似于BLC在形态上类似于HPV相关的鳞状细胞癌。该子集可能代表比当前定义的BLC更同质的组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号